In the modern world, sleep disorders have become one of the major public health challenges. Now, Nyxoah, a leading company in medical technologies, is seeking to answer the question of whether real-world evidence can aid in the broader acceptance of the Genio device.
Genio: Innovation in Sleep Disorder Treatment
The Genio device, specifically designed for the treatment of sleep apnea, utilizes nerve stimulation technology to help patients achieve better sleep. Given the increasing demand for effective sleep disorder treatments, this technology could be presented as an innovative solution in this field.
The BREATHE study focuses on collecting real-world evidence from patients and physicians, aiming to examine the actual experiences of users with the Genio device. This study is conducted to evaluate the clinical effects and quality of life of patients, and its results could serve as a credible source for both doctors and patients.
Challenges and Opportunities
However, the adoption of new technologies in the medical field is always faced with challenges. Among these challenges is the resistance of some doctors and patients to change. Meanwhile, real-world evidence can act as a powerful tool for shifting attitudes and increasing the acceptance of Genio.
Research shows that patients generally have more trust in treatment methods that have documented and reliable evidence. Therefore, the success of the BREATHE study could enhance public confidence in the Genio device and ultimately improve the sleep quality of millions.
In the medical world, real-world evidence not only aids in the acceptance of new technologies but can also lead to positive changes in health policies. For this reason, the results of this study could have impacts beyond the therapeutic realm and serve as a model for other technologies as well.
